Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background:
Quorum quenching, the interference of a Quorum sensing (QS) system that contributes to the pathogenesis through triggering the production of various virulence determinants, is among the newly suggested antivirulence strategies.
Purpose:
This study aimed at screening of N-Acyl homoserine
lactonase
activity from local bacterial isolate, and investigating its effect on
Pseudomonas aeruginosa
(
P. aeruginosa
) virulence and biofilm formation.
Materials and methods:
Soil bacteria were screened for
aiiA
gene coding for
lactonase
enzyme by Polymerase Chain reaction and sequencing of
aiiA
gene homologs. Lactonase activity and spectrum were assessed in the cell-free lysate by well diffusion assay using
Agrobacterium tumafaciens
KYC55. A bacterial isolate showing the highest N-acyl-homoserine lactones degradation percentage was identified by gene amplification and sequencing of the 16S rRNA gene and its
aiiA
gene homolog. High performance liquid chromatography was used to confirm N-acyl-homoserine lactone degradation. The effect of cell-free lysate on the biofilm formation ability and cytotoxicity of
P. aeruginosa
PAO1 and
P. aeruginosa
clinical isolates from different clinical sources were assessed by static microtiter plate and viability assay, respectively
Results:
Lactonase gene and activity were identified in three
Bacillus
spp. isolates. They showed broad catalytic activities against tested N-acyl-homoserine lactones. However, The
lactonase
activity in the cell- free lysate of isolate 30b showed the highest significant degradation percentage on all tested signals; N-butanoyl-L-homoserine lactone (71%), N-hexanoyl-l-homoserine lactone (100%), N-decanoyl-homoserine lactone (100%), N-(3-oxohexanoyl)-L-homoserine lactone (37.5%), N-(oxodecanoyl)-L-homoserine lactone (100%), and N-(3-oxododecanoyl)-L-homoserine lactone (100%). Alignment of the amino acid sequences of AiiA protein of isolate 30b showed 96% identity with
Bacillus cereus
(
B. cereus
) homologous lactonases in the GenBank database, and the isolate was designated as
B. cereus
isolate 30b. Cell-free lysate of
B. cereus
isolate 30b reduced biofilm formation significantly in 93% of
P. aeruginosa
isolates. The highest mean percentage of reduction in the biofilm was 86%. Moreover, the viability percentage of human
lung carcinoma
A549 cells infected by
P. aeruginosa
and treated with cell-free lysate of
B. cereus
isolate 30b increased up to 15%.
Conclusion:
The results of this study highlight the potential of lactonases as a promising strategy to combat
Pseudomonas aeruginosa
virulence.
...
PMID:Quorum quenching activity of
Bacillus cereus
isolate 30b confers antipathogenic effects in
Pseudomonas aeruginosa
. 3123 33